Daiichi Sankyo
A global pharmaceutical company with corporate origins in Japan, Daiichi Sankyo provides innovative products and services in more than 30 countries/regions around the world. Their science and technology is firmly rooted in patient-centricity. Learn more.
GE HealthCare
GE HealthCare partners with customers to fulfill healthcare’s greatest potential through groundbreaking medical technology, intelligent devices, and care solutions—better tools enabling better patient care, creating a world where healthcare has no limits.
Learn more.
Lilly Oncology
Since 1961, Lilly has been dedicated to delivering life-changing medicines for people living with cancer. Their scientists are urgently advancing new discoveries with the goal of transforming some of the most difficult-to-treat cancers into manageable diseases. Learn more.
Merck Pharmaceuticals
Aspiring to be the premier research-intensive biopharmaceutical company, Merck is at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. Learn more.
Novartis
Novartis is an innovative company working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Their medicines reach 296 million people worldwide. Learn more.
Olema Oncology
Olema is a cancer medicines company on a mission to elevate patient care in breast cancer and beyond. Their team of oncology experts works to create more effective, safe, and convenient treatments to help people living with cancer feel better, longer. Learn more.
Pfizer
Pfizer’s purpose is breakthroughs that change patients’ lives. Pursuing that goal relentlessly and innovating every day to make the world a healthier place, they are fighting for eight cancer breakthroughs by 2030.
Learn more.
Sermonix Pharmaceuticals
This privately held biotechnology company has a precision medicine focus on the development and commercialization of female-specific oncology products including oral lasofoxifene, an investigational novel endocrine therapy in clinical development. Learn more.
Stemline Therapeutics
Stemline Therapeutics, part of the Menarini Group, is focused on improving the lives of cancer patients by developing and commercializing novel first-in-class therapeutics that target difficult-to-treat cancers. Their products include ELZONRIS and ORSERDU. Learn more.
